Company Filing History:
Years Active: 1977-1978
Title: The Innovative Contributions of Clarence DeBoer
Introduction
Clarence DeBoer is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotic formulations. With a total of 2 patents, his work has had a meaningful impact on treating infectious diseases in both humans and animals.
Latest Patents
DeBoer's latest patents include a composition of matter and process for novel antibiotic formulations of antibiotic 354 (U-54,703). This invention focuses on their use in treating susceptible infectious diseases. Additionally, he has developed therapeutic compositions of antibiotic U-44,590, which includes methods for using pharmaceutical compositions of this antibiotic and its derivatives. These formulations are designed to treat Gram-negative and Gram-positive bacterial and viral diseases.
Career Highlights
Throughout his career, Clarence DeBoer has been associated with The Upjohn Company, where he has contributed to various innovative projects. His expertise in antibiotic formulations has positioned him as a key figure in the pharmaceutical industry.
Collaborations
DeBoer has worked alongside notable colleagues such as Brian Bannister and Harold E. Renis. Their collaborative efforts have further advanced the research and development of effective antibiotic treatments.
Conclusion
Clarence DeBoer's innovative work in antibiotic formulations has made a significant impact on the treatment of infectious diseases. His contributions continue to influence the pharmaceutical landscape, showcasing the importance of research and innovation in healthcare.